Acurx Pharmaceuticals Inc ACXP:NASDAQ

RT Quote | NASDAQ | USD
Last | 07/01/22 EDT
3.71quote price arrow down-0.08 (-2.24%)
Volume
9,877
52 week range
2.33 - 6.84
Loading...
  • Open3.82
  • Day High3.82
  • Day Low3.63
  • Prev Close3.79
  • 52 Week High6.84
  • 52 Week High Date07/01/21
  • 52 Week Low2.33
  • 52 Week Low Date05/24/22

Key Stats

  • Market Cap38.01M
  • Shares Out10.26M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-13.22

KEY STATS

  • Open3.82
  • Day High3.82
  • Day Low3.63
  • Prev Close3.79
  • 52 Week High6.84
  • 52 Week High Date07/01/21
  • 52 Week Low2.33
  • 52 Week Low Date05/24/22
  • Market Cap38.01M
  • Shares Out10.26M
  • 10 Day Average Volume0.01M
  • Dividend-
  • Dividend Yield-
  • Beta-
  • YTD % Change-13.22

RATIOS/PROFITABILITY

  • EPS (TTM)-1.55
  • P/E (TTM)-2.39
  • Fwd P/E (NTM)-
  • EBITDA (TTM)-14.01M
  • ROE (TTM)-211.90%
  • Revenue (TTM)0.00
  • Gross Margin (TTM)-
  • Net Margin (TTM)-
  • Debt To Equity (MRQ)0.00%

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Acurx Pharmaceuticals Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Acurx Pharmaceuticals, Inc., formerly Acurx Pharmaceuticals, LLC, is a clinical-stage biopharmaceutical company. The Company is engaged in developing a class of antibiotics for infections caused by bacteria listed as pathogens by the World Health Organization (WHO), the United States Centers for Disease Control and Prevention, and the United States Food and Drug Administration (FDA). The Company develops antibiotic candidates that block the deoxyribonucleic acid (DNA)...
Address
259 Liberty Avenue
Staten Island, NY
10305
United States